Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Vaccine|February 2, 2023
Spontaneous reports of primary ovarian insufficiency after vaccination: A review of the vaccine adverse event reporting system (VAERS)A Patricia Wodi, Paige Marquez, Adamma Mba-Jonas, et al.
JAMA|October 7, 2021
Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barré Syndrome, February-July 2021Emily Jane Woo, Adamma Mba-Jonas, Rositsa B Dimova, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|October 25, 2017
Reports of Postural Orthostatic Tachycardia Syndrome After Human Papillomavirus Vaccination in the Vaccine Adverse Event Reporting SystemJorge Arana, Adamma Mba-Jonas, Christopher Jankosky, et al.
Plos One|March 4, 2014
Treatment and outcomes among patients with Cryptococcus gattii infections in the United States Pacific NorthwestRachel M Smith, Adamma Mba-Jonas, Mathieu Tourdjman, et al.
Pediatrics|November 20, 2019
Safety of the 9-Valent Human Papillomavirus VaccineTom T Shimabukuro, John R Su, Paige L Marquez, et al.
British Journal of Clinical Pharmacology|September 20, 2018
Safety of bivalent human papillomavirus vaccine in the US vaccine adverse event reporting system (VAERS), 2009-2017Tiffany A Suragh, Paige Lewis, Jorge Arana, et al.
Pharmacoepidemiology and Drug Safety|September 6, 2022
Thromboembolic events after Ad.26.COV2.S COVID-19 vaccine: Reports to the Vaccine Adverse Event Reporting SystemEmily Jane Woo, Adamma Mba-Jonas, Alisha Thomas, et al.
Vaccine|February 26, 2018
Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015Jorge E Arana, Theresa Harrington, Maria Cano, et al.
American Journal of Epidemiology|June 4, 2018
Assessment of Quadrivalent Human Papillomavirus Vaccine Safety Using the Self-Controlled Tree-Temporal Scan Statistic Signal-Detection Method in the Sentinel SystemW Katherine Yih, Judith C Maro, Michael Nguyen, et al.
Vaccine|April 30, 2022
Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 - October 2021Pedro L Moro, Christine K Olson, Elizabeth Clark, et al.
Pageof 2